The Effects of Hypoalbuminaemia on Optimizing Antibacterial Dosing in Critically Ill Patients, Clinical Pharmacokinetics, vol.20, issue.5, pp.99-110, 2011. ,
DOI : 10.2165/11539220-000000000-00000
Population pharmacokinetic study of teicoplanin in severely neutropenic patients, Antimicrob Agents Ch, vol.40, issue.5, pp.1242-1249, 1996. ,
Pharmacokinetics of teicoplanin upon multiple-dose intravenous administration of 3, 12, and 30 milligrams per kilogram of body weight to healthy male volunteers., Antimicrobial Agents and Chemotherapy, vol.36, issue.1, pp.115-120, 1992. ,
DOI : 10.1128/AAC.36.1.115
Pharmacokinetics of teicoplanin in the elderly, Journal of Antimicrobial Chemotherapy, vol.21, issue.suppl A, pp.39-45, 1988. ,
DOI : 10.1093/jac/21.suppl_A.39
Teicoplanin therapy for Staphylococcus aureus septicaemia: relationship between pre-dose serum concentrations and outcome, Journal of Antimicrobial Chemotherapy, vol.45, issue.6, pp.835-876, 2000. ,
DOI : 10.1093/jac/45.6.835
Pharmacodynamics, Pharmacokinetics, and Therapeutic Drug Monitoring of Glycopeptides, Therapeutic Drug Monitoring, vol.20, issue.5, pp.473-480, 1998. ,
DOI : 10.1097/00007691-199810000-00005
Applied Pharmacokinetics: Principles of Therapeutic Drug Monitoring, Applied Therapeutics, 1992. ,
Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose, Journal of Antimicrobial Chemotherapy, vol.51, issue.4, pp.971-976, 2003. ,
DOI : 10.1093/jac/dkg147
Influence of Underlying Disease on Busulfan Disposition in Pediatric Bone Marrow Transplant Recipients: A Nonparametric Population Pharmacokinetic Study, Therapeutic Drug Monitoring, vol.29, issue.2, pp.177-84, 2007. ,
DOI : 10.1097/FTD.0b013e318039b478
Some suggestions for measuring predictive performance, Journal of Pharmacokinetics and Biopharmaceutics, vol.61, issue.4, pp.503-515, 1981. ,
DOI : 10.1007/BF01060893
Variabilit?? pharmacocin??tique intra-individuelle et traitement antibiotique prolong??, M??decine et Maladies Infectieuses, vol.40, issue.1, pp.38-41, 2010. ,
DOI : 10.1016/j.medmal.2009.03.003
Estimation of Creatinine Clearance in Patients with Unstable Renal Function, without a Urine Specimen, American Journal of Nephrology, vol.22, issue.4, pp.320-324, 2002. ,
DOI : 10.1159/000065221
Niveau de preuve du suivi th??rapeutique pharmacologique de la teicoplanine, Th??rapie, vol.66, issue.1, pp.45-50, 2011. ,
DOI : 10.2515/therapie/2011003
Clinical Pharmacokinetics of Teicoplanin, Clinical Pharmacokinetics, vol.44, issue.3, pp.167-83, 2000. ,
DOI : 10.2165/00003088-200039030-00001
Vancomycin, Clinical Pharmacokinetics, vol.259, issue.1, pp.1-13, 2012. ,
DOI : 10.2165/11596390-000000000-00000
Niveau de preuve pour le suivi th??rapeutique pharmacologique de la vancomycine, Th??rapie, vol.66, issue.1, pp.29-37, 2011. ,
DOI : 10.2515/therapie/2011005
Evaluation of glycopeptide use in nine French hospitals, M??decine et Maladies Infectieuses, vol.40, issue.4, pp.232-239, 2010. ,
DOI : 10.1016/j.medmal.2009.10.019
The effect of multifactorial, multidisciplinary educational interventions on appropriate use of teicoplanin, International Journal of Antimicrobial Agents, vol.27, issue.4, pp.344-50, 2006. ,
DOI : 10.1016/j.ijantimicag.2005.11.012
Effect of a Comprehensive, Multidisciplinary, Educational Program on the Use of Antibiotics in a Geriatric University Hospital, Journal of the American Geriatrics Society, vol.342, issue.1, pp.112-118, 2004. ,
DOI : 10.1111/j.1532-5415.2004.52019.x